Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2003Transplantation

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1

View Full Paper
Ask AI
Bookmark
Share

Authors

SJStanley C. JordanCedars-Sinai Medical CenterAVAshley VoCedars-Sinai Medical CenterSBSuphamai BunnapradistUniversity of California, Los Angeles

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jordan et al. (2003) studied this question.

synapsesocial.com/papers/6a7972e72eb3c7e469f38dadhttps://doi.org/10.1097/01.tp.0000080685.31697.fc
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1POSTTRANSPLANT THERAPY USING HIGH-DOSE HUMAN IMMUNOGLOBULIN (INTRAVENOUS GAMMAGLOBULIN) TO CONTROL ACUTE HUMORAL REJECTION IN RENAL AND CARDIAC ALLOGRAFT RECIPIENTS AND POTENTIAL MECHANISM OF ACTION11998 · 269 citations
  2. 2SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg)1993 · 169 citations
  3. 3Significance of the Positive Crossmatch Test in Kidney Transplantation1969 · 1,514 citations
  4. 4INTRAVENOUS IMMUNOGLOBULIN SUPPRESSION OF HLA ALLOANTIBODY IN HIGHLY SENSITIZED TRANSPLANT CANDIDATES AND TRANSPLANTATION WITH A HISTOINCOMPATIBLE ORGAN1994 · 233 citations
  5. 5Improved Graft Survival after Renal Transplantation in the United States, 1988 to 19962000 · 1,853 citations